Grace Marianne Facio

Title(s)Nurse Navigator, RN
SchoolKeck School of Medicine of Usc
AddressIRD 525
Health Sciences Campus
Los Angeles CA 90089-9520
Phone+1 323 865 3922
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer. Gynecol Oncol. 2023 06; 173:49-57. Garcia-Sayre J, Lin YG, Matsuo K, Tsao-Wei DD, Mhawech-Fauceglia P, Louie S, Dong T, Ciccone MA, Brunette-Masi LL, Pham HQ, Yessaian AA, Groshen SG, Facio G, Aldana M, Muderspach LI, Garcia AA, Roman LD. PMID: 37079977.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    2. Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer. Cancer Invest. 2012 May; 30(4):295-9. Garcia AA, Yessaian A, Pham H, Facio G, Muderspach L, Roman L. PMID: 22468744.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    3. A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Gynecol Oncol. 2007 Sep; 106(3):558-66. Roman LD, Wilczynski S, Muderspach LI, Burnett AF, O'Meara A, Brinkman JA, Kast WM, Facio G, Felix JC, Aldana M, Weber JS. PMID: 17631950.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsCTClinical Trials
    4. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin. Cancer Invest. 2005; 23(8):665-70. Garcia AA, Roman L, Muderspach L, O'meara A, Facio G, Edwards S, Burnett A. PMID: 16377584.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    5. Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. Gynecol Oncol. 2004 May; 93(2):493-8. Garcia AA, O'Meara A, Bahador A, Facio G, Jeffers S, Kim DY, Roman L. PMID: 15099968.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Grace's Networks
    Concepts (39)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (10)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.